MedTrace Logo

Micronutrient-supplemented Milk Study in Women of Childbearing Age

NCT01712165 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 70

Last updated 2013-10-11

No results posted yet for this study

Summary

The purpose of this study is to determine if consuming ANMUM Materna (a fortified milk product) over a 12-week period increases red blood cell folate concentrations in women of childbearing age in Singapore, compared to an equivalent amount of standard (unfortified) milk.

Conditions

  • Increase the Concentration of Folic Acid in Women of Childbearing Age

Interventions

DIETARY_SUPPLEMENT

ANMUM Materna

DIETARY_SUPPLEMENT

Control (milk powder)

Sponsors & Collaborators

  • Changi General Hospital

    collaborator OTHER

  • Fonterra Research Centre

    lead INDUSTRY

Principal Investigators

  • Magdalin Cheong · Changi General Hospital

Study Design

Allocation
RANDOMIZED
Purpose
HEALTH_SERVICES_RESEARCH
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
21 Years
Max Age
35 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2013-06-30
Primary Completion
2013-10-31
Completion
2013-10-31

Countries

  • Singapore

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01712165 on ClinicalTrials.gov